Abstract
The syndrome of psychological dependence on psychoactive substances (SPD) is the most important element in the pathogenesis of the addictive diseases (narcoticism and alcoholism). Studies of this syndrome are possible on the basis of the achievements of a number of sciences including neurobiology, neurochemistry, physiology, and psychology. In recent years, changes in signal transduction systems occurring during the chronic action of psychoactive substances have been investigated in detail. It is believed that such disorders are involved in the development of the SPD. These problems are discussed in connection with the prophylaxis and treatment of addictive diseases.
Similar content being viewed by others
Abbreviations
- CRF:
-
corticotrophin releasing factor
- DA:
-
dopamine
- EAA:
-
exitatory amino acids
- PAS:
-
psychoactive substances
- SPD:
-
syndrome of psychological dependence
References
Val’dman, A.V., Babayan, E.A., and Zvartau, E.E., Psikhofarmakologicheskie i medico-pravovye aspekty toksikomanii (Psycopharmacological and Medicojural Aspects of Toxicomanias), Moscow: Meditsina, 1988.
Sudakov, S.K. and Sudakov, K.V., Narkologiya, 2003, no. 1, pp. 38–43.
Pyatnitskaya, I. N., Narkomanii: Rukovodstvo dlya vrachei (Drug Addictions: Handbook for Doctors), Moscow: Meditsina, 1994.
Shabalina, V. V., Psikhologiya zavisimogo povedeniya: Na primere povedeniya, svyazannogo s potrebleniem narkotikov i drugikh psikhoaktivnykh veshchestv (Psychology of Dependent Behavior: On the Example of Behavior Associated with Use of Narcotics and Other Psychoactive Substances), SPb: St. Petersburg University, 2004.
Zvartau, E.E., Metodologya izucheniya narkotoksikomanii (Methodology of Studies of Narcotoxicomanias), Itogi nauki i tekhniki, VINITI, ser. Narcology, 1988, vol. 1.
Cami, J., Farre, M., New Engl. J. Med., 2003, vol. 349, no. 10, pp. 975–986.
Entsiklopedia medizinskikh terminov (Encyclopedia of Medical Terms), Petrovskii, B.V., Ed., Moscow: Sovetskaya Entsyklopediya, 1984, vol. 3.
Sudakov, K.V., Zh. Nevrologii i Psikhiatrii im. Korsakova, S.S., 2000, vol. 100, no. 10, pp. 7–17.
Slovar’fisiologicheskikh terminov (Dictionary of Physiological Terms), Gazenko, O.G., Ed., Moscow: Nauka, 1987.
Lichko, A.E. and Bitenskii, V.S., Podrostkovaya narkomaniya: Rukovodstvo (Adolescent Narcotism: Handbook), Leningrad: Meditsina, 1991.
Sudakov, K.V., Vestn. Ross. Akad. Med. Nauk, 2001, no. 4, pp. 3–12.
Sudakov, K.V., Vestn. Ross. Akad. Med. Nauk, 1997, no. 12, pp. 52–56.
Ykhtomskii, A.A., Dominanta, Moscow-Leningrad: Nauka, 1966.
Shabanov, P.D., Nozdrachev, A.D., Lebedev, A.A., and Lebedev, V.A., Ros. Fisiol. Zh. im. Sechenova, I.M., 2000, vol. 86, no. 8, pp. 935–945.
Koob, G.F. and Bloom, F.E., Science, 1988, vol. 242, no. 4879, pp. 715–723.
Koob, G.F. and Le Moal, M., Neuropsychopharmacology. 2001, vol. 24, no. 2, pp. 97–129.
Bozarth, M.A. and Wise, R.A., Prog. Neuropsychopharmacol. Biol. Psychiatry, 1983, vol. 7, no. 4–6, pp. 569–575.
Wise, R.A. and Bozarth, M.A., Psychiatr. Med., 1985, vol. 3, no. 4, pp. 445–460.
Robinson, T.E. and Berridge, K.C., Annu. Rev. Psychol., 2003, vol. 54, pp. 25–53.
Van Ree, J.M., Gerrits, M.A.F.M., Vanderschuren, L.J.M.J., Pharmacol. Rev., 1999, vol. 51, no. 2, pp. 341–396.
White, F.J., J. Neurosci., 2002, vol. 22, no. 9, pp. 3303–3305.
Golikov, S.N., Sanotskii, I.V., and Tiunov, L.A., Obshchie mekhanismy toksicheskogo deistviya (General Mechanisms of Toxic Action), Leningrad: Meditsyna, 1986.
Agatsuma, S. and Hiroi, N., Nihon Shinkei Seishin Yakurigaku Zasshi, 2004, vol. 24, no. 3, pp. 137–145 (Articlein Japanese).
Beitner-Johnson, D., Guitart, X., and Nestler, E.J. Brain Res., 1991, vol. 561, no. 1, pp. 147–150.
Guitart, X., Beitner-Johnson, D., Marby, D.W., et al., Synapse, 1992, vol. 12, no. 3, pp. 242–253.
Anokhina, I.P., Veretinskaya, A.G., and Vekshina, N.L., Vopr. Narkologii, 2003, no. 6, pp. 62–68.
Anokhina, I.P., Ivanets, N.N., Shamakina, I.Yu., et al., Nrkologiya, 2004, no. 6, pp. 71–77.
Lektsyi po narkologii (Lectures on Narcology), Ivanets, N.N., Ed., Moscow: Nolidzh, 2000.
Bardo, M.T. Crit. Rev. Neurobiol., 1998, vol. 12, no. 1–2, pp. 37–67.
De Vries, T.J. and Shippenberg, T.S., J. Neurosci., 2002, vol. 22, no. 9, pp. 3321–3325.
Rocha, B.A., Scearce-Levie, K., Lucas, J.J., et al., Nature, 1998, vol. 393, no. 6681, pp. 175–178.
Acquas, E. and Di Chiara, G. J. Neurochem., 1992, vol. 58, no. 5, pp. 1620–1625.
Fuentealba, J.A., Forray, M.I., Gysling, K., J. Neurochem., 2000, vol. 75, no. 2, pp. 741–748.
Moises, H.C. and Smith, C.B., Brain Res., 1987, vol. 400, no. 1, pp. 110–126.
Tjon, G.H., De Vries, T.J., Ronken, E., et al., Eur. J. Pharmacol., 1994, vol. 252, no. 2, pp. 205–212.
Turchan, J., Lason, W., Budziszewska, B., and Przewlocka, B., Neuropeptides, 1997, vol. 31, no. 1, pp. 24–28.
Shalev, U., Grimm, J.W., and Shaham, Y., Pharmacol. Rev., 2002, vol. 54, no. 1. pp. 1–42.
Salamone, J.D. and Correa, M., Behav. Brain Res., 2002, vol. 137, no. 1–2, pp. 3–25.
Bosse, A. and Kuschinsky, K., Naunyn-Schmiedeberg’s Arch. Pharmacol., 1976, vol. 294, no. 1, pp. 17–22.
Diana, M., Muntoni, A.L., Pistis, M., et al., Eur. J. Neurosci., 1999, vol. 11, no. 3, pp. 1037–1041.
Diana, M., Pistis, M., Muntoni, A., and Gessa, G., J. Pharmacol. Exp. Ther., 1995, vol. 272, no. 2, pp. 781–785.
Honkanen, A., Piepponen, T.P., and Ahtee, L., Neurosci. Lett., 1994, vol. 180, no. 2, pp. 119–122.
Lee, J.M., DeLeon-Jones, F., Fields, J.Z., and Ritzmann, R.F., Alcohol. Drug. Res., 1987, vol. 7, no. 1, pp. 1–10.
Martin, J.R. and Takemori, A.E., Eur. J. Pharmacol., 1986, vol. 121, no. 2, pp. 221–229.
Casas, M., Guardia, J., Prat, G., and Trujols, J., Addiction, 1995, vol. 90, no. 6, pp. 831–835.
Stinus, L., Nadaud, D., Deminiere, J.M., et al., Biol. Psychiatry, 1989, vol. 26, no. 4, pp. 363–371.
Kozlov, A.A., Rokhlina, M.L., Chistyakova, L.A., and Ogar’, D.V., Narkologiya, 2004, no. 8, pp. 50–58.
Spielewoy, C., Gonon, F., Roubert, C., et al., Eur. J. Neurosci., 2000, vol. 12, no. 5, pp. 1827–1837.
Noda, Y. and Nabeshima, T., Nippon Yakurigaku Zasshi, 2002, vol. 119, no. 4, pp. 213–217 (Article in Japanese).
Noda, Y., Mamiya, T., and Nabeshima, T., NipponY-akurigaku Zasshi, 2001, vol. 117, no. 1, pp. 21–26 (Articlein Japanese).
Nakajima, S., Neurosci. Biobehav. Rev., 1989, vol. 13, no. 2–3, pp. 123–128.
Smith, J.W., Fetsko, L.A., Xu, R., and Wang, Y., Neuroscience, 2002, vol. 113, no. 4, pp. 755–765.
Walters, C.L. and Blendy, J.A., J. Neurosci., 2001, vol. 21, no. 23, pp. 9438–9444.
Carlezon, W.A.Jr., Thome, J., and Olson, V.G., et al., Science, 1998, vol. 282, no. 5397, pp. 2272–2275.
Hiroi, N., Brown, J.R., Haile, C.N., et al., Proc. Natl. Acad. Sci., U. S. A., 1997, vol. 94, no. 19, pp. 10397–10402.
Bespalov, A.Yu. and Zvartau, E.E., Neiropsikhofarmacologiya antagonistov NMDA-retseptorov (Neuropcychofarmacology of Antagonists of the NMDA Receptors), SPb: Nevskii dialect, 2000.
Hummel, M. and Unterwald, E.M., J. Cell. Physiol., 2002, vol. 191, no. 1, pp. 17–27.
Haile, C.N., Hiroi, N., Nestler, E.J., and Kosten, T.A., Synapse, 2001, vol. 41, no. 3, pp. 179–190.
Nylander, I., Vlaskovska, M., and Terenius, L., Brain Res., 1995, vol. 683, no. 1, pp. 25–35.
Nabeshima, A., Toki, S., Saito, T., and Takahata, N., Nihon Shinkei Seishin Yakurigaku Zasshi, 1995, vol. 15, no. 4, pp. 345–353 (Article in Japanese).
Werme, M., Thoren, P., Olson, L., and Brene, S., Eur. J. Neurosci., 2000, vol. 12, no. 8, pp. 2967–2974.
Werme, M., Olson, L., and Brene, S., Mol. Brain Res., 2000, vol. 76, no. 1, pp. 18–24.
Maldonado, R. and Rodriguez de Fonseca, F., J. Neurosci., 2002, vol. 22, no. 9, pp. 3326–3331.
Anokhina, I.P., Lektsyi po narkologii (Lectures on Narcology), Ivanets, N.N., Ed., Moscow: Nolidzh, 2000, pp. 16–40.
Wang, G.J., Volkow, N.D., Fowler, J.S., et al., Neuropsychopharmacology, 1997, vol. 16, no. 2, pp. 174–182.
Wong, D.F., Maini, A., Rousset, O.G., and Brasic, J.R., Alcohol. Res. Health., 2003, vol. 27, no. 2, pp. 161–173.
Kotler, M., Cohen, H., Segman, R., et al., Mol. Psychiatry, 1997, vol. 2, no. 3, pp. 251–254.
Li, T., Xu, K., Deng, H., et al., Mol. Psychiatry, 1997, vol. 2, no. 5, pp. 413–416.
Li, T., Liu, X., Zhao, J., et al., Am. J. Med. Genet., 2002, vol. 114, no. 3, pp. 329–335.
Gelernter, J., Kranzler, H., and Lacobelle, J., Genomics, 1998, vol. 52, no. 3, pp. 289–297.
Schuckit, M.A., Mazzanti, C., Smith T.L., et al., Biol. Psychiatry, 1999, vol. 45, no. 5, pp. 647–651.
Raevskii, K.S., and Georgiev, V.P., Mediatornye aminokisloty: neirofarmakologicheskie i neirokhimicheskie aspekty (Mediator Amino Acids: Neuropharmacological and neurochemical aspects), Moscow: Meditsyna, 1986.
Leshner, A.I. and Koob, G.F., Proc. Assoc. Am. Physicians, 1999, vol. 111, no. 2, pp. 99–108.
McBride, W.J., Murphy, J.M., and Ikemoto, S., Behav. Brain Res., 1999, vol. 101, no. 2, pp. 129–152.
Bespalov, A.Y., Balster, R.L., and Beardsley, P.M., J. Pharmacol. Exp. Ther., 1999, vol. 290, no. 1, pp. 20–27.
Popik, P., Mamczarz, J., Fraczek, M., et al., Neuropharmacology, 1998, vol. 37, no. 8, pp. 1033–1042.
Hodge, C.W., Cox, A.A., and Bratt, A.M., Psychopharmacology (Berlin), 2001, vol. 154, no. 1, pp. 13–22.
Watanabe, T., Nakagawa, T., Yamamoto, R., et al., Jpn. J. Pharmacol., 2002, vol. 88, no. 4, pp. 399–406.
Rasmussen, K., Neuropsychopharmacology, 1995, vol. 13, no. 4, pp. 295–300.
Belozertseva, I.V., Danysz, W., and Bespalov, A.Y., Naunyn-Schmiedeberg″s Arch. Pharmacol., 2000, vol. 361, no. 3, pp. 279–282.
Zarrindast, M.R. and Mousa-Ahmadi, E., Eur. J. Pharmacol., 1999, vol. 381, no. 2–3, pp. 129–133.
Petrie, J., Sapp, D.W., Tyndale, R.F., et al., Alcohol. Clin. Exp. Res., 2001, vol. 25, no. 6, pp. 819–828.
Cummins, J.T., Sack, M., and von Hungen, K., Life Sci., 1990, vol. 47, no. 10, pp. 877–882.
Kang, M., Spigelman, I., Sapp, D.W., and Olsen, R.W., Brain Res., 1996, vol. 709, no. 2, pp. 221–228.
Cadete-Leite, A., Brandao, F., Andrade, J.P., et al., Alcohol Alcohol., 1997, vol. 32, no. 4, pp. 471–484.
Martin, G., Ahmed, S.H., Blank, T., et al., J. Neurosci., 1999, vol. 19, no. 20, pp. 9081–9089.
Eravci, M., Schulz, O., Grospietsch, T., et al., Br. J. Pharmacol., 2000, vol. 131, no. 3, pp. 423–432.
Tremwel, M.F. and Hunter, B.E., Synapse, 1994, vol. 17, no. 2, pp. 141–148.
Congeddu, E., Saba, L., Porcella, A., et al., Mol. Brain Res., 2003, vol. 110, no. 2, pp. 289–297.
Loh, E.W. and Ball, D., Neurochem. Int., 2000, vol. 37, no. 5–6, pp. 413–423.
Saba, L., Porcella, A., Congeddu, E., et al., Mol. Brain Res., 2001, vol. 87, no. 2, pp. 263–270.
Chen, F., Rezvani, A., Jarrott, B., and Lawrence, A.J., Neurochem. Int., 1998, vol. 32, no. 2, pp. 143–151.
Sanna, A., Congeddu, E., Saba, L., et al., Brain Res., 2004, vol. 998, no. 2, pp. 148–154.
Malatynska, E., Dyr, W., Krzascik, P., and Kostowski, W., Alcohol Alcohol., 2001, vol. 36, no. 4, pp. 309–313.
Burov, Yu.V. and Zhukov, V.N., Teoreticheskie osnovy poiska sredstv dlya lecheniya alkogolisma (Theoretical Basis of a Search for Means for the Treatment of Alcoholism), Itogi nauki i tekhniki, VINITI, ser. Toksikologiya, Val’dman, A.V., Ed., 1988, vol. 13, pp. 57–92.
Ostrovskii, Yu. M. and Sadovnik, M.I., Teoreticheskie osnovy poiska sredstv dlya lecheniya alkogolisma (Theoretical Basis of a Search for Means for the Treatment of Alcoholism), Itogi nauki i tekhniki, VINITI, ser. Toksikologiya, Val’dman, A.V., Ed., 1988, vol. 13, pp. 93–150.
Mitchem, L.D., Kruschel, C.K., Dallman, E., et al., Pharmacol. Biochem. Behav., 1999, vol. 62, no. 1, pp. 97–102.
June, H.L., Grey, C., Warren-Reese, C., et al., Alcohol. Clin. Exp. Res., 1998, vol. 22, no. 9, pp. 2174–2185.
Piepponen, T.P., Kivastik, T., Katajamaki, J., et al., Pharmacol. Biochem. Behav., 1997, vol. 58, no. 1, pp. 275–279.
Matthes, H.W., Maldonado, R., Simonin, F., et al., Nature, 1996, vol. 383, no. 6603, pp. 819–823.
Berrendero, F., Kieffer, B.L., and Maldonado, R., J. Neurosci., 2002, vol. 22, no. 24, pp. 10935–10940.
Bohn, L.M., Gainetdinov, R.R., Sotnikova, T.D., et al., J. Neurosci., 2003, vol. 23, no. 32, pp. 10265–10273.
Suzuki, T., Ikeda, H., Tsuji, M., et al., Life Sci., 1997, vol. 61, no. 11, pp. PL 165–170.
Nylander, I., Vlaskovska, M., and Terenius, L., Brain Res., 1995, vol. 683, no. 1, pp. 25–35.
Bond, C., LaForge, K.S., Tian, M., et al., Proc. Natl. Acad. Sci. U. S. A., 1998, vol. 95, no. 16, pp. 9608–9613.
Shi, J., Hui, L., Xu, Y., et al., Hum. Mutat., 2002, vol. 19, no. 4, pp. 459–460.
Franke, P., Nothen, M.M., Wang, T., et al., Am. J. Med. Genet., 1999, vol. 88, no. 5, pp. 462–464.
Mayer, P., Rochlitz, H., Rauch, E., et al., Neuroreport., 1997, vol. 8, no. 11, pp. 2547–2550.
Ide, S., Kobayashi, H., Tanaka, K., et al., Ann. N.Y. Acad. Sci., 2004, vol. 1025, pp. 316–324.
Mas-Nieto, M., Pommier, B., Tzavara, E.T., et al., Br. J. Pharmacol., 2001, vol. 132, no. 8, pp. 1809–1816.
Sarnyai, Z., Shaham, Y., and Heinrichs, S.C., Pharmacol. Rev., 2001, vol. 53, no. 2, pp. 209–244.
Basile, A.S., Fedorova, I., Zapata, A., et al., Proc. Natl. Acad. Sci. U. S. A., 2002, vol. 99, no. 17, pp. 11452–11457.
Navarro, M., Carrera, M.R., Fratta, W., et al., J. Neurosci., 2001, vol. 21, no. 14, pp. 5344–5350.
Pontieri, F.E., Monnazzi, P., Scontrini, A., et al., Eur. J.Pharmacol., 2001, vol. 421, no. 3, pp. R1–3.
Vigano, D., Grazia Cascio, M., Rubino, T., et al., Neuropsychopharmacology., 2003, vol. 28, no. 6, pp. 1160–1167.
Castane, A., Valjent, E., Ledent, C., et al., Neuropharmacology, 2002, vol. 43, no. 5, pp. 857–867.
Cossu, G., Ledent, C., Fattore, L., et al., Behav. Brain Res, 2001, vol. 118, no. 1, pp. 61–65.
Martin, M., Ledent, C., Parmentier, M., et al., Eur. J. Neurosci., 2000, vol. 12, no. 11, pp. 4038–4046.
Naassila, M., Pierrefiche, O., Ledent, C., and Daoust, M., Neuropharamcology, 2004, vol. 46, no. 2, pp. 243–253.
Rice, O.V., Gordon, N., and Gifford, A.N., Brain Res., 2002, vol. 945, no. 1, pp. 135–138.
Reibaud, M., Obinu, M.C., Ledent, C., et al., Eur. J. Pharmacol., 1999, vol. 379, no. 1, pp. R1–2.
Bohme, G.A., Laville, M., Ledent, C., et al., Neuroscience, 2000, vol. 95, no. 1, pp. 5–7.
Kunos, G. and Batkai, S., Neurochem. Res., 2001, vol.26, no. 8–9, pp. 1015–1021.
Comings, D.E., Muhleman, D., Gade, R., et al., Mol. Psychiatry, 1997, vol. 2, no. 2, pp. 161–168.
Heller, d., Schneider, U., Seifert, J., et al., Addict. Biol., 2001, vol. 6, no. 2, pp. 183–187.
Zhang, P.W., Ishiguro, H., Ohtsuki, T., et al., Mol. Psychiatry, 2004, vol. 9, no. 10, pp. 916–931.
Koob, G.F., Neuropsychopharmacol., 2003, vol. 13, no. 6, pp. 442–52.
Koob, G.F. and Weiss, F., Recent Dev. Alcohol., 1992, vol. 10, pp. 201–233.
Weiss, F., Ciccocioppo, R., Parsons, L.H., et al., Ann. N. Y. Acad. Sci., 2001, vol. 937, pp. 1–26.
Sarnyai, Z. and Kovacs, G.L., Psychoneuroendocrinology 1994, vol. 19, no. 1, pp. 85–117.
Meunier, J.C., Therapie, 2001, vol. 56, no. 3, pp. 227–234 (Article in French).
Murtra, P., Sheasby, A.M., Hunt, S.P., and De Felipo, C., Nature, 2000, vol. 405, no. 6783, pp. 180–183.
De Jong, I.E.M. and De Kloet, E.R., Ann. N. Y. Acad. Sci., 2004, vol. 1018, no. 1, pp. 192–198.
Hamdy, M.M., Mamiya, T., Noda, Y., et al., Behav. Brain Res., 2001, vol. 118, no. 1, pp. 85–93.
Kaewsuk, S., Hutamekalin, P., Ketterman, A.J., et al., Eur. J. Pharmacol., 2001, vol. 411, no. 1–2, pp. 11–16.
Machelska, H., Ziolkowska, B., Mika, J., et al., Neuroreport., 1997, vol. 8, no. 12, pp. 2743–2747.
Przewlocka, B., Lason, W., Przewlocki, R., Neuroscience, 1994, vol. 63, no. 4, pp. 1111–1116.
Kumar, S. and Bhargava, H.N., Gen. Pharmacol., 1997, vol. 29, no. 2, pp. 223–227.
Ikemoto, M., Osugi, T., Wang, X.B., et al., Neuroreport., 1995, vol. 6, no. 2, pp. 262–264.
Osugi, T., Ikemoto, M., Tanaka, H., et al., Mol. Brain Res., 1994, vol. 21, no 3–4. pp. 256–262.
Lou, L., Zhou, T., Wang, P., and Pei, G., Mol. Pharmacol., 1999, vol. 55, no. 3, pp. 557–563.
Garcia, M.M., Gilster, J., and Harlan, R.E., Brain Res., 1996, vol. 734, no. 1–2, pp. 123–134.
Erdtmann-Vourliotis, M., Mayer, P., Riechert, U., and Hollt, V., Mol. Brain Res., 1999, vol. 71, no. 2, pp. 313–324.
Shichinohe, S., Ozawa, H., Saito, T., et al., Alcohol. Clin. Exp. Res., 1998, vol. 22, no. 3, Suppl. pp. 84S–87S.
Escriba, P.V., Sastre, M., and Garcia-Sevilla, J.A., Arch. Gen. Psychiatry, 1994, vol. 51, no. 6, pp. 494–501.
Garcia-Sevilla, J.A., Ventayol, P., Busquets, X., et al., Neurosci. Lett., 1997, vol. 226, no. 1, pp. 29–32.
Hashimoto, E., Frolich, L., Ozawa, H., et al., Alcohol. Clin. Exp. Res., 1996, vol. 20, no. 9, Suppl. pp. 301A–304A.
Busquets, X., Escriba, P.V., Sastre, M., and Garcia-Sevilla, J.A., J. Neurochem., 1995, vol. 64, no. 1, pp. 247–252.
Ferrer-Alcon, M., La Harpe, R., and Garcia-Sevilla, J.A., Mol. Brain Res., 2004, vol. 121, no. 1–2, pp. 114–122.
Ozaita, A., Escriba, P.V., Ventayol, P., et al., J. Neurochem., 1998, vol. 70, no. 3, pp. 1249–1257.
Bishop, G., Cullinan, W., Curran, E., and Gutstein, H., Neurobiol. Dis., 2002, vol. 10, no. 3, p. 334.
Erdtmann-Vourliotis, M., Mayer, P., Linke, R., et al., Mol. Brain Res., 1999, vol. 72, no. 1, pp. 1–16.
Erdtmann-Vourliotis, M., Mayer, P., Riechert, U., et al., Mol. Brain Res., 1998, vol. 61, no. 1–2, pp. 51–61.
Pontieri, F.E., Calo, L., Di Grezia, R., et al., Eur. J. Pharmacol., 1997, vol. 335, no. 2–3, pp. 133–137.
Frankel, P.S., Harlan, R.E., and Garcia, M.M., Brain Res., 1999, vol. 835, no. 2, pp. 204–212.
Tolliver, B.K., Sganga, M.W., and Sharp, F.R., Eur. J. Neurosci., 2000, vol. 12, no. 9, pp. 3399–3406.
Lu, L., Zeng, S., Liu, D., and Ceng, X., Neurosci. Lett., 2000, vol. 291, no. 3, pp. 191–195.
Fan, G.H., Wang, L.Z., Qiu, H.C., et al., Mol. Pharmacol., 1999, vol. 56, no. 1, pp. 39–45.
Krupitskii, E.M., Burakov, A.M., Priputina, L.S., et al., Zh. Nevrologii i psikhiatrii im Korsakova, S.S., 2004, vol. 104, no. 7, pp. 50–53.
Antidepressanty b terapii patologicheskogo vlecheniya k psikhotropnym veshchestvam (Antidepressants in Theraphy of Pathological Attraction to Psychotropic Substances), Ivanets, N.N., Ed., Moscow: Politek-F, 2000.
Shabanov, P.D. and Shtakel’berg, O.Yu., Narkomanii: patopsikhologiya, klinika, reabilitatsyya (Narcotism: Pathological Psychology, Clinics, Reabilitation), Grinenko, A.Ya., Ed., SPb: Lan’, 2000.
Ivanets, N.N. and Vinnikova, M.A., Heroinovaya narkomaniya (postabstinentnoe sostoyanie: klinika i lechenie (Heroin Narcotism (Posyabstinence: Clinics and Treatment), Moscow: Medpractika, 2000.
Voronin, K.E., Lektsii po narkologii (Lectures on Narcology), Ivanets, N.N., Ed., Moscow: Nolidzh, 2000, pp. 250–270.
Wilde, M.I. and Wagstaff, A.J., Drugs, 1997, vol. 53, no. 6, pp. 1038–1053.
Krutitskii, E.M., Zvartau, E.E., Masalov, D.V., et al., Psikhiatriya konsul’tirovaniya i vzaimodeistviya (Psychiatry of Consultation and Interaction), Vanchakova, N.P., Ed., 2003, pp. 54–55.
Vetulani, J., Pol. J. Pharmacol., 2001, vol. 53, no. 5, pp. 415–434.
Khersh, D., Peili, D. Renner, D.A. Jn., Narcologiya (Narcology), Fridman, L.S., Fleming, N.S., Roberts, D.Kh., and Khaiman, S.E., Moscow-SPb: Binom, Nevskii dialect, 1998, pp. 187–199.
Sivolap, Yu.P., and Savchenkov, V.A., Zh. Nevrologii i psikhiatrii im. Korsakova, S.S., 2000, vol. 100, no. 5, pp. 66–70.
O’Malley, S.S. and Froehlich, J.C., Recent Dev. Alcohol., 2003, vol. 16, pp. 217–245.
Olsen, L., Christophersen, A.S., Frogopsahl. G., et al., Br. J. Clin. Pharmacol., 2004, vol. 58, no. 2, pp. 219–222.
Collins, S.L. and Kantak, K.M., Psychopharmacology (Berlin), 2002, vol. 159, no. 4, pp. 361–369.
Lallemand, F. and De Witte, P., Pharmacol. Biochem. Behav., 1997, vol. 58, no. 3, pp. 753–761.
Self, D.W., Genova, L.M., Hope, B.T., et al., J. Neurosci., 1998, vol. 18, no. 5, pp. 1848–1859.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.I. Golovko, S.I. Golovko, L.V. Leontieva, 2007, published in Neirokhimiya, 2006, Vol. 23, No. 1, pp. 5–18.
Rights and permissions
About this article
Cite this article
Golovko, A.I., Golovko, S.I. & Leontieva, L.V. The neurochemistry of the psychological dependence syndrome in addictive diseases of chemical etiology. Neurochem. J. 1, 1–13 (2007). https://doi.org/10.1134/S1819712407010011
Received:
Issue Date:
DOI: https://doi.org/10.1134/S1819712407010011